US Stocks
/
Actinium Pharmaceuticals, Inc Share Price

Actinium Pharmaceuticals, Inc Share Price

AMEX: ATNM | Micro Cap
$1.08
+0.00 (0.00%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Actinium Pharmaceuticals, Inc Stock Performance

Open
$1.08
Prev. Close
$1.08
Circuit Range
N/A
Day Range
$1.08 - $1.08
Year Range
$0.75 - $1.73
Volume
190
Average Traded
$1.08

Actinium Pharmaceuticals, Inc Share Price Today

As of 11 October 2026, Actinium Pharmaceuticals, Inc's share price is $1.08. The stock opened at $1.08, compared to its previous close of $1.08. During today's trading session, Actinium Pharmaceuticals, Inc's share price traded between $1.08 and $1.08, with an average price of $1.08. Over the past 52 weeks, the stock has recorded a high of $1.73 and a low of $0.75. In terms of performance, Actinium Pharmaceuticals, Inc's share price has declined by 3.57% over the last six months and is down 23.94% on a year-on-year basis.

Actinium Pharmaceuticals, Inc Share Price Chart

$1.08$1.08
L
Show Current Price
H

Actinium Pharmaceuticals, Inc Stock Fundamentals & Key Indicators

Market Cap
$33.69M
PE Ratio (TTM)
3.06
Dividend Yield
0.00%
EPS (TTM)
$0.36
Revenue (TTM)
$90.00M
Return On Equity (TTM)
37.32%
Profit Margin
-37655.56%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
643.86%

Actinium Pharmaceuticals, Inc Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.09$0.00$0.00$35.00
Net Profit-$5.13-$5.94-$5.52$27.90
Net Profit Margin-5700.00%N/AN/A79.71%
Income ChangeN/A-15.79%7.07%605.43%

Actinium Pharmaceuticals, Inc Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.03$0.08$0.00$0.09
Net Profit-$33.02-$48.82-$38.24-$33.89
Net Profit Margin-3205.83%-61025.00%N/A-37655.56%
Income ChangeN/A-47.85%21.67%11.38%

About Actinium Pharmaceuticals, Inc

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

Actinium Pharmaceuticals, Inc Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.15
$1.08
-5.65%
Sep 2026
$1.02
$1.15
+13.41%
Aug 2026
$0.85
$1.01
+20.71%
Jul 2026
$0.97
$0.84
-14.37%
Jun 2026
$1.21
$0.98
-21.83%
May 2026
$1.13
$1.25
+12.05%
Apr 2026
$0.99
$1.12
+14.05%
Mar 2026
$1.16
$0.98
-18.17%
Feb 2026
$1.22
$1.20
+3.45%
Jan 2026
$1.35
$1.16
-15.33%
Dec 2025
$1.39
$1.37
-2.49%
Nov 2025
$1.39
$1.41
-1.06%

ATNM Share Price FAQs

What is Actinium Pharmaceuticals, Inc share price today?

chevron-up
Actinium Pharmaceuticals, Inc share price today is $1.08 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Actinium Pharmaceuticals, Inc stock?

chevron-up
The 52 week high of Actinium Pharmaceuticals, Inc stock is $1.73, while the 52 week low is $0.75 as of 10 Oct '26.

What is ATNM's market capitalisation today?

chevron-up
ATNM market capitalisation is $33.69M as of October 11, 2026, at 2:07 am IST.

What is ATNM's net income for the last quarter?

chevron-up
ATNM's net income for the last quarter is 27.90B USD.

What is the 5 year returns of ATNM?

chevron-up
The 5 year returns of ATNM is -86.35% as on 10 Oct '26.

What is the high & low stock price of ATNM today?

chevron-up
ATNM stock price hit a high of $1.08 and low of $1.08 as of 10 Oct '26.

Can I buy ATNM shares in India?

chevron-up
Yes. You can buy ATNM in India by opening an international trading account.